Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
This is the latest in a long line of cases alleging state prison systems are unfairly warehousing treatment.
The World Health Organization wants to see 90 percent of the world’s population screened for hepatitis C by 2030.
Local advocacy groups say misinformation and stigma have prevented the majority of people who need the lifesaving drug from accessing it.
The state will classify Sovaldi, Harvoni and Viekira Pak as ’preferred drugs’ and will also simplify prior authorization.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.